These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15095141)

  • 1. Kava does not display metabolic toxicity in a homogeneous cellular assay.
    Zou L; Harkey MR; Henderson GL; Dike LE
    Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
    Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
    Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
    Anke J; Fu S; Ramzan I
    Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
    Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
    Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
    Uebelhack R; Franke L; Schewe HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kavalactones Yangonin and Methysticin induce apoptosis in human hepatocytes (HepG2) in vitro.
    Tang J; Dunlop RA; Rowe A; Rodgers KJ; Ramzan I
    Phytother Res; 2011 Mar; 25(3):417-23. PubMed ID: 20734326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
    Mathews JM; Etheridge AS; Black SR
    Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
    Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
    Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
    Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
    Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
    Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
    J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
    Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
    J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum).
    Hashimoto T; Suganuma M; Fujiki H; Yamada M; Kohno T; Asakawa Y
    Phytomedicine; 2003 May; 10(4):309-17. PubMed ID: 12809361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.